Fun Facts about Cancun with Synergy

One month ago today, we posted a video and introduction to our 2014 Cancun vacation destination. Hopefully that inspired a series of daydreams for you, dreams in which you find yourself on those sandy beaches with the sun on your face and a tropical beverage in your hand.

Synergy North America Team Members: There are still three months left to qualify! Those dreams are within reach— let us help you make them a reality!

In these last three months, as you push yourself to qualify, here are a few fun facts about Cancun to keep you motivated:

1. The average annual temperature in Cancun is 80 degrees Fahrenheit, arguably the most perfect temperature of all temperatures.
2. Cancun is wonderfully sunny 240 days of the year. The other days may have a cloud or two, maybe even a little rain… but they call it paradise for good reason.
3. Cancun’s beaches have white sand, which is made from crushed coral and is not hot to the touch. Just think: Mother Nature spent all that time crushing up coral so you’d have a comfy place to relax next March.
4. In early 2010,
   

   there was a major beach restoration project that included the rebuilding of the beaches in Cancun, Playa del Carmen, and Cozumel. The Mexican government invested $71 million US Dollars in the project, which restored 11 kilometers of the area’s beaches. Again, all that money was spent just for you, so that you would have a comfy place to relax with us next March.

5. “Cancun” is the Mayan word for “Nest of Snakes.” I guess snakes are pretty smart. Who wouldn’t want a nest in paradise? For those afraid of snakes… don’t worry. Statistically, you will have a very, very small chance of encountering a snake while vacationing at the Moon Palace with us.
6. This Cancun vacation will be very fun. We will have much more fun, however, if you are with us. That’s a fact.

Remember, you have until the end of the year to make this happen. We’ll be staying at the luxurious Moon Palace Golf & Spa Resort from March 20-23 and we are extremely excited. For more information on what it takes to qualify for this Cancun vacation on Synergy’s dime, click here.

Dr. Böger on ProArgi-9+, ADMA and Synergy

Earlier today, Dr. Rainer Böger called from Germany to be joined by a large number of listeners. As this month’s Cardio Call special guest, he explained ProArgi-9+ and the way it acts in the body. If you were unable to join the call don’t worry— the call has been recorded and you can listen to it here at your convenience.

Click to listen to the 2013 October Cardio Call with Dr. Rainer Böger.

Remember, you can listen to a variety of past Cardio Call recordings at any time by clicking the “Resources” tab at the top of this page.

Dr. Böger on ADMA

Some of the major achievements of Dr. Böger’s career involve his research on asymmetric dimethylarginine (ADMA) as a risk marker of vascular disease. In today’s Cardio Call, he took time to address the subject of ADMA and a misunderstanding that is becoming all too common in the industry.

Some have suggested that because ADMA blocks l-arginine that it thereby cancels out all potential benefits of ProArgi-9+ in the body. However, the truth as pointed out by Dr. Böger is that the presence of ADMA in a person’s body is the very reason high quality l-arginine supplementation is so necessary.

“We see 2 out of 3 people have a deficite in l-arginine,” says Dr. Böger. “This, in most people, is not true because they have such low levels of arginine in the blood, but because they have high levels of ADMA in the blood. When someone has high ADMA, that person is in need of additional arginine from a dietary supplement. People who have high ADMA have a high need of l-arginine from ProArgi-9+. We have data to show that for explicitly those with a high ADMA, l-arginine supplements will work well. For those with a low ADMA, the need to have a high dose of arginine supplements is not so great.”

Be sure to listen to the rest of the recording as he explores this subject in greater detail.

About Dr. Böger

Professor Rainer H. Böger, MD, is a leading expert in L-arginine research and member of Synergy’s Medical and Scientific Advisory Board.

After receiving his initial medical training at Hannover Medical School in Hannover, Germany, Dr. Böger then received his postgraduate training in Internal Medicine and Pharmacology both in Hannover and at Stanford University School of Medicine in Stanford, CA.

Dr. Böger is currently the Professor of Clinical Pharmacology and Director of the Institute of Clinical Pharmacology and Toxicology at Hamburg University Medical Center, Germany. He is also Director of the Clinical Trial Center North at Hamburg University.

Dr. Böger’s scientific work centers on the early diagnosis and prevention of cardiovascular related diseases. Dating back to the beginning of his medical career, Dr. Böger has been heavily involved in the research and treatment of cardiovascular related diseases. In 1991, while working closely with pharmaceutical drug companies to develop treatments that could combat and alleviate such diseases, he became highly interested in nitric oxide (NO) and its effects on the vascular system.

Over 23 years of academic research has been conducted by Dr. Böger in basic science and clinical studies related to L-arginine and its influence on the body’s ability to produce NO.
Dr. Böger collaborates with renowned institutions like the Mayo Clinic and Stanford University Medical Center. Dr. Böger’s extensive knowledge, expertise, and ongoing research clearly set him apart as one of the world’s leading L-arginine experts

Join us for next month’s Cardio Call on November 13, 2013.

Global Summit Summary & Recap Video

While many of us are finding ourselves in the dropping temperatures of fall, Dan Austin, Howard Hannemann and many other Synergy leaders are heading toward the warmth of Arizona! If you are able to be in the Phoenix/Mesa area next week, October 11th and 12th, join us for two valuable events, including a special session of Synergy’s Gold Camp.

Featuring Dan Austin, the Chief Cardiac Care Nurse of the High Desert Heart Institute, along with Director of Sales Howard Hannemann and Presidential Executive Rudy Pedroza, this 2-event weekend will help you make the most of the Synergy Advantage.

Friday, October 11 will be the date of our Opportunity Meeting event, open to all guests and family ($5 entry fee for Team Members, all guests are FREE). Here, Dan Austin will speak about what truly makes ProArgi-9+ so important and powerful, while Howard and Rudy speak about the value of our company overall and the opportunities it provides.

Saturday, October 12  is the day for Gold Camp. This will be a morning dedicated to educating Synergy business builders. Leverage the bonuses, make the most of Mega Match, recruit, retain and achieve the results you’ve been hoping for. Gold Camp is only $15 per attendee, and you can register for this event by clicking here.

VENUE INFO, SCHEDULE & AGENDA

FRIDAY
Time: 7 to 8:30 PM
Location: Hilton Hotel – 1011 W. Holmes Ave.- Kiva C – Mesa, Arizona 85210
Team Members are encouraged to bring guests to this event.

SATURDAY – GOLD CAMP
Time: 9 AM to 1 PM
Location: Hilton Hotel – 1011 W. Holmes Ave.- Kiva C – Mesa, Arizona 85210
Register Here
Note: Team Members planning to attend both events can pay both entry fees on our secure registration page.

For additional information, you can check the Synergy Calendar or the event registration page.

To learn more about Dan Austin, click here.

October Cardio Call with Dr. Böger

On Wednesday, October 9, Dr. Rainer Böger, a world-leading expert in L-arginine research and member of Synergy’s Medical and Scientific Advisory Board, will join us as the featured speaker for this month’s Cardio Call!

Cardio Call with Dr. Böger 
When: Wednesday, October 9, 2013.
Time: 9:30 AM Mountain Time
(8:30 AM PT, 10:30 AM CT, 11:30 AM ET).

To Join the Call, Dial:
Phone: 1-800-832-4695
Pin: 8908#

Please note, Dr. Böger will be participating from Germany – an eight hour time difference. For this reason, the call will be held at 9:30 AM Mountain Time. It will also be recorded for those who are unable to listen live.

Mark your calendars and don’t miss this opportunity for you, your team, and your guests to learn why Dr. Böger believes ProArgi-9+ to be the superior L-arginine supplement on the market today.

Important Playback Information

Blog Recordings Tab
Click here to view the Recordings tab 
The recording will be available later in the day, following the live call on Wednesday, October 9.

About Dr. Rainer Böger

Dr. Böger is currently the Professor of Clinical Pharmacology and Director of the Institute of Clinical Pharmacology and Toxicology at Hamburg University Medical Center, Germany. He is also Director of the Clinical Trial Center North at Hamburg University.

Dr. Böger’s scientific work centers on the early diagnosis and prevention of cardiovascular related diseases. Dating back to the beginning of his medical career, Dr. Böger has been heavily involved in the research and treatment of cardiovascular related diseases. In 1991, while working closely with pharmaceutical drug companies to develop treatments that could combat and alleviate such diseases, he became highly interested in nitric oxide (NO) and its effects on the vascular system.

Dr. Böger has dedicated 21 years of academic research in basic science and clinical studies related to L-arginine and its influence on the body’s ability to produce NO. His major achievements are the discovery that ADMA (asymmetric dimethylarginine) is a risk marker of vascular disease and the utilization of L-arginine to prevent vascular dysfunction and disease.

Dr. Böger collaborates with renowned institutions like the Mayo Clinic and Stanford University Medical Center. He has documented his knowledge in more than 200 scientific articles, of which 130 exclusively cover the roles of ADMA and L-arginine in cardiovascular and metabolic diseases.

Dr. Böger’s extensive knowledge, expertise, and ongoing research clearly set him apart as one of the world’s leading L-arginine experts. It’s an honor to have Dr. Böger as part of the Synergy WorldWide team.